[The effect of hexonium on the biochemical and morphologic changes in the wall of a stomach affected by neurogenic dystrophy].
D000818:Animals; D005730:Ganglionic Blockers / Q000627:therapeutic use*; D005753:Gastric Mucosa / Q000378:metabolism*; D006584:Hexamethonium Compounds / Q000627:therapeutic use*; D007103:Immobilization; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D012019:Reflex Sympathetic Dystrophy / Q000188:drug therapy* / Q000378:metabolism; D013272:Stomach Diseases / Q000188:drug therapy* / Q000378:metabolism; D013276:Stomach Ulcer / Q000378:metabolism / Q000517:prevention & control*
D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D009638:Norepinephrine
Vliianie geksoniia na biokhimicheskie i morfologicheskie izmeneniia v stenke zheludka pri neĭrogennoĭ ee distrofii.